Drugs / Netilimicin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06404541 Comparator | Jan → Apr 2024 | dry eye syndrome | Kasr El Aini Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Netilimicin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06404541 ↗ |
| Route | Topical | “20 eyes received single dose unit Dexathalm containing: actives: In 1ml: Dexamethason 1mg and Netilimicin 3mg, without preservatives 5 times per day.” NCT06404541 ↗ |